TTK Healthcare Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

T. Raghunathan

Chief Executive Officer (CEO)

₹41.0m

Compensación total

Porcentaje del salario del CEO	14.6%
Permanencia del CEO	9.8yrs
Participación del CEO	0.3%
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	9.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de T. Raghunathan en comparación con los beneficios de TTK Healthcare?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	₹650m
Sep 30 2023	n/a	n/a	₹641m
Jun 30 2023	n/a	n/a	₹560m
Mar 31 2023	₹41m	₹6m	₹447m
Dec 31 2022	n/a	n/a	₹285m
Sep 30 2022	n/a	n/a	₹226m
Jun 30 2022	n/a	n/a	₹185m
Mar 31 2022	₹31m	₹5m	₹185m
Dec 31 2021	n/a	n/a	₹413m
Sep 30 2021	n/a	n/a	₹368m
Jun 30 2021	n/a	n/a	₹548m
Mar 31 2021	₹20m	₹4m	₹368m
Dec 31 2020	n/a	n/a	₹365m
Sep 30 2020	n/a	n/a	₹333m
Jun 30 2020	n/a	n/a	₹63m
Mar 31 2020	₹11m	₹4m	₹123m
Dec 31 2019	n/a	n/a	₹169m
Sep 30 2019	n/a	n/a	₹173m
Jun 30 2019	n/a	n/a	₹201m
Mar 31 2019	₹21m	₹4m	₹244m
Dec 31 2018	n/a	n/a	₹274m
Sep 30 2018	n/a	n/a	₹348m
Jun 30 2018	n/a	n/a	₹393m
Mar 31 2018	₹16m	₹4m	₹182m

Compensación vs. Mercado: La compensación total de T.($USD492.53K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD187.48K).

Compensación vs. Ingresos: La compensación de T. ha aumentado más de un 20% en el último año.

CEO

T. Raghunathan (71 yo)

9.8yrs

Permanencia

₹41,034,005

Compensación

Mr. T. T. Raghunathan, B.Com., has been the Chief Executive Officer of TTK Healthcare Limited since August 22, 2014. Mr. Raghunathan has been Managing Director of TTK - LIG Ltd., since February 01, 2013. M...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
T. Raghunathan	Executive Chairman & CEO	25.4yrs	₹41.03m	0.27% ₹ 56.7m
S. Kalyanaraman	Secretary	9.8yrs	₹30.18m	0.0031% ₹ 631.6k
Vandana Walvekar	Independent Director	9.8yrs	₹320.00k	sin datos
Krishnamurthy Shankaran	Non-Executive Director	23.6yrs	₹780.00k	0.0018% ₹ 361.2k
Girish Rao	Independent Director	9.8yrs	₹480.00k	sin datos
R. Tulshan	Non-Executive Non-Independent Director	39.5yrs	₹440.00k	0.22% ₹ 46.0m
Thattai Mukund	Non Executive Non-Independent Director	1.7yrs	₹120.00k	0.10% ₹ 20.6m
S. Balasubramanian	Independent Director	9.2yrs	₹540.00k	sin datos
Ramesh Natarajan	Independent Director	8.3yrs	₹380.00k	sin datos
V. Ranganathan	Independent Director	4.9yrs	₹360.00k	sin datos

9.8yrs

Permanencia media

67.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 507747 se considera experimentada (9.7 años de antigüedad promedio).

TTK Healthcare Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024

TTK Healthcare Limited, Annual General Meeting, Jul 25, 2023

Insufficient new directors

TTK Healthcare Limited Announces Board Changes

Insufficient new directors

Insufficient new directors

Recent updates

TTK Healthcare Limited to Report Fiscal Year 2024 Results on May 24, 2024

TTK Healthcare Limited Appoints S Kalyanaraman as Chief Executive Officer, Effective 1 June, 2024

TTK Healthcare Limited to Report Q2, 2024 Results on Nov 03, 2023

TTK Healthcare Voluntary Delisting Offer Fails

TTK Healthcare Limited to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of ₹10.00 per share at 0.8% yield

TTK Healthcare Limited, Annual General Meeting, Jul 25, 2023

Full year 2023 earnings released: EPS: ₹31.61 (vs ₹13.10 in FY 2022)

Investor sentiment improves as stock rises 25%

Investor sentiment improves as stock rises 19%

Third quarter 2023 earnings released: EPS: ₹8.49 (vs ₹8.61 in 3Q 2022)

TTK Healthcare Limited to Report Q3, 2022 Results on Feb 07, 2023

Insufficient new directors

Second quarter 2023 earnings released

TTK Healthcare Limited to Report Q2, 2023 Results on Oct 28, 2022

TTK Healthcare Limited Announces Board Changes

TTK Healthcare Limited Approves Dividend for the Year Ended March 31, 2022

Upcoming dividend of ₹10.00 per share

TTK Healthcare Limited to Report Q1, 2023 Results on Jul 26, 2022

TTK Healthcare Limited to Report Q1, 2023 Results on Jul 26, 2022

Full year 2022 earnings released: EPS: ₹13.10 (vs ₹26.03 in FY 2021)

Full year 2022 earnings released: EPS: ₹13.10 (vs ₹32.87 in FY 2021)

TTK Healthcare Limited Board Meeting Approves Dividend for the Financial Year Ended 31Ch March, 2022

BSV Pharma Private Limited completed the acquisition of Human Pharma Division of TTK Healthcare Limited (BSE:507747) for INR 8.05 billion.

Insufficient new directors

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

Second quarter 2022 earnings released: EPS ₹9.07 (vs ₹21.80 in 2Q 2021)

Upcoming dividend of ₹6.00 per share

Full year 2021 earnings released: EPS ₹32.87 (vs ₹8.72 in FY 2020)

Full year 2021 earnings released: EPS ₹32.87 (vs ₹8.72 in FY 2020)

TTK Healthcare Limited Recommends Dividend for the Financial Year Ended March 31, 2021

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹5.44 (vs ₹3.17 in 3Q 2020)

New 90-day high: ₹609

TTK Healthcare Limited to Report Q3, 2021 Results on Feb 04, 2021

Market bids up stock over the past week

New 90-day high: ₹492

Second quarter 2021 earnings released: EPS ₹21.80

First quarter earnings released

New 90-day high - ₹471

TTK Healthcare Limited to Report Q4, 2020 Results on Jul 22, 2020

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Miembros de la Junta

Permanencia media

Promedio de edad